Posts Tagged ‘pancreas’

An artificial pancreas invented can bring an end to the misery of daily injections for diabetics

An artificial pancreas invented can bring an end to the misery of daily injections for diabetics

It’s the first device approved by the FDA that detects dropping sugar levels and shuts off regular insulin delivery for Type 1 diabetics, just like a real pancreas is one of  the Best Inventions of the Year 2013 .Too much insulin, which is common at night, can lead to life-threatening diabetic comas.

An artificial pancreas invented by a De Montfort University (DMU) professor could have its first human trials within two years.

Professor Joan Taylor’s creation ensures patients will no longer have to endure injections of insulin every day.

Instead, a device will be surgically implanted into the body and able to release a precise amount of insulin into the bloodstream. Supplies would be topped up every two weeks.

Human trials are due to begin in 2016 with the first implants taking place on the NHS within a decade – news which has featured prominently in the national press with articles in the Daily Express and the Daily Mail among others.

Professor of Pharmacy at DMU, Joan Taylor, said: “The device will not only remove the need to manually inject insulin, but will also ensure that perfect doses are administrated each and every time. By controlling blood glucose so effectively, we should be able to help reduce related health problems.

“We are extremely close to embarking on clinical trials. Diabetes is costing society more than £1million an hour in treatment, and much of that is spent on treating complications.”

The implant contains a reservoir of insulin kept in place by a special gel barrier. When glucose levels in the body rise, the gel liquefies and releases the insulin into the body, mimicking the normal pancreas.

As the insulin lowers the glucose levels, the gel reacts by hardening again and preserving the reservoir. It would eliminate the need for diabetics to inject insulin up to four times a day.

The artificial pancreas will help all Type 1 insulin-dependent diabetics and some suffering Type 2 who need daily injections.

Professor Taylor has spent 20 years developing the device, which requires no electronics. This means the risk of rejection by the body is minimised.

Until now, the project has had funding of £1 million from the NHS, the Lachesis Fund – which invests in research in the university – the charity Edith Murphy Foundation and private backers. Professor Taylor is now seeking a similar amount to refine the product.

“This device is cheap and simple to use,” added Professor Taylor. “It has the potential to bring an end to the misery of daily injections for diabetics.”


Full story

Airport security scanners may affect function of insulin pump or CGM devices

Airport security scanners may affect function of insulin pump or CGM devices

Full-body or X-ray scanners used for airport security screening may affect the function of insulin pump or continuous glucose monitoring (CGM) devices. People with diabetes can present a travel letter obtained from their physicians to avoid possible damage caused by exposure to imaging equipment in airports. The risk to these sensitive devices posed by scanners and the low-pressure conditions on airplanes are the focus of the Editorial “Navigating Airport Security with an Insulin Pump and/or Sensor,” published in Diabetes Technology & Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The Editorial is available free on the Diabetes Technology & Therapeutics website at

Andrew Cornish and H. Peter Chase, MD, University of Colorado, Denver, caution that the motor of an insulin delivery pump or glucose monitoring device may experience electromagnetic malfunctioning when passed through an airport security scanner. However, little research has been published on the potential impact of that exposure.

“Given the increased use of insulin pump therapy, not only in the U.S., but around the world, with hundreds of thousands of people using this technology, it seems critical that more research is funded to better understand and potentially repair this problem,” says Irl Hirsch, MD, Senior Editor of Diabetes Technology & Therapeutics and Professor of Medicine, University of Washington Medical Center-Roosevelt, Seattle, WA.

Source :

Full story

Afinitor (Everolimus) For Rare Pancreatic Cancer Approved By FDA

Afinitor (Everolimus) For Rare Pancreatic Cancer Approved By FDA

"Patients with this cancer have few effective treatment options. Afinitor has demonstrated the ability to slow the growth and spread of neuroendocrine tumors of the pancreas."

Full story

Comprehensive diagnosis for early detection of breast cancer

Comprehensive diagnosis for early detection of breast cancer

Comprehensive diagnosis for early detection of breast cancer

New software combines key imaging techniques for breast diagnostics on a single workstation

Erlangen, Germany, 2010-Oct-04

The latest version of Syngo Mammo Report, the mammography workstation from Siemens, for the first time combines tomosynthesis, 3D ultrasound and 3D magnetic resonance imaging (MRI) with 2D mammography. That way, breast care specialists can interpret images from various examinations of one patient at a glance.

When mammography indicates a lump in the breast, radiologists often have to use additional imaging methods to acquire a detailed diagnosis. To assess the various images from ultrasound, MRI, and mammography systems, there is usually a dedicated workstation respectively. The latest version of the mammography workstation Syngo Mammo Report from Siemens enables radiologists to display images from different examinations simultaneously. In addition to saving time, the direct comparison of results allows for a more comprehensive diagnosis. Furthermore, Syngo Mammo Report supports 3D applications for ultrasound, mammography, and MRI. Three-dimensional imaging techniques are becoming increasingly important in the early detection of breast cancer, particularly for patients with dense breast tissue or with a family history of breast cancer.

Syngo Mammo Report also allows users to read images from other vendors’ imaging systems. Moreover, the workstation can be integrated into the radiology information systems of different departments, such as the breast center or the radiology department.

The Siemens Healthcare Sector is one of the world’s largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 48,000 employees worldwide and operates around the world. In fiscal year 2009 (to September 30), the Sector posted revenue of 11.9 billion euros and profit of around 1.5 billion euros. For further information please visit:

The products mentioned here are not commercially available in all countries. Due to regulatory reasons the future availability in any country cannot be guaranteed. Further details are available from the local Siemens organizations.

The outcomes achieved by the Siemens customers described herein were achieved in the customer’s unique setting.   Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that others will achieve the same results.

Reference Number: H201010058e,12787,12755,1022266~a_langId~e_-11~a_productId~e_18081~a_storeId~e_10001.htm

Related Posts Plugin for WordPress, Blogger...

Full story

Copyright © 2018 Medical Technology & Gadgets Blog All rights reserved.
Proudly powered by WordPress. Developed by Deluxe Themes